• 118: Gaining Patient Perspectives on Impact of Narcolepsy

  • Jun 28 2024
  • Length: 19 mins
  • Podcast

118: Gaining Patient Perspectives on Impact of Narcolepsy cover art

118: Gaining Patient Perspectives on Impact of Narcolepsy

Listen for free

View show details

  • Summary

  • Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.


    In this episode, Anne Marie Morse, DO, FAAN, a pediatric neurologist and sleep medicine specialist at Geisinger Medical Center, sat down at the 2024 SLEEP Annual Meeting to discuss a poster presentation highlighting a listening analysis that characterized the struggles and unmet needs of people with narcolepsy. in the discussion, Morse outlined some of the major findings, including the rates of missed and misdiagnosis, how cataplexy impacts daily life, and some of the other comorbidities associated with the condition. She spoke on the value of gaining patient perspectives and using their descriptions for their disorders helps in understanding true unmet needs. Furthermore, she spoke on the importance of a strong patient-clinician relationship, the ability to communicate openly, and the steps following diagnosis to ensure effective long-term treatment outcomes.


    Looking for more sleep disorders discussion? Check out the NeurologyLive® sleep disorders clinical focus page.

    Episode Breakdown:
    • 1:10 – Motivations behind conducting listening analysis
    • 3:15 – Major clinical takeaways from study; notable quality of life impairments in narcolepsy
    • 7:00 – Impact of cataplexy and patients' overreaction
    • 9:50 – Neurology News Minute
    • 12:20 – Reasons for missed and misdiagnosis
    • 14:50 – Early tips to pathing patients towards treatment success

    The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:

    • FDA Grants Traditional Approval to Elevidys Gene Therapy for Ambulatory DMD, Accelerated Approval for Nonambulatory Patients
    • FDA Approves Efgartigimod as New Treatment for Chronic Inflammatory Demyelinating Polyneuropathy
    • FDA Approves Pitolisant for Excessive Daytime Sleepiness in Pediatric Narcolepsy

    Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.
    Show More Show Less
Physical Illness & Disease Hygiene & Healthy Living Science
Show More Show Less

What listeners say about 118: Gaining Patient Perspectives on Impact of Narcolepsy

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.